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ABSTRACT

Percutaneous Endoscopic Gastrostomy Placement Time in People with Cystic Fibrosis

by

Sarah Gunnell, Master of Science
Utah State University, 2002

Major Professor: Nedra K. Christensen
Department: Nutrition and Food Sciences

A retrospective chart review was conducted on pediatric patients at the
Intermountain Cystic Fibrosis Center who had a percutaneous endoscopic gastrostomy
(PEG) placed between 1993 and 1999. Height velocity improved significantly in the
group of patients with a PEG placed; however, pulmonary function declined more
significantly over time.
Questiom1aires regarding attitude toward PEG placement were sent to patients
enrolled in accredited cystic fibrosis centers in the mountain west region and to their
parents. The overall response rate was 54.25% for the PEG questionnaire and 24% for
the non-PEG questionnaire. Ninety-six percent of the patients with a PEG reported that
weight was a problem at time of placement, and 91 % reported weight gain after PEG
placement. Sixty-four percent of the patients with a PEG reported that they would have a
PEG placed if they made the decision again. Of the patients without a PEG, 60.7%
thought a PEG looked bad, and 59.2% would be embarrassed to have a PEG. Forty-nine
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percent of patients without a PEG expressed a lack of knowledge of the pros and cons of
PEG placement and 35.4% had no opinion about their knowledge of PEGs.
PEG placement can be beneficial in improving nutritional status. Optimal time for
PEG placement may be earlier rather than after pulmonary function has declined. People
with a PEG have felt positive toward placement, and those without a PEG seem to lack
knowledge about the pros and cons of PEG placement. (63 pages)
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CHAPTER I
GENERAL BACKGROUND AND INTRODUCTION

Definition and Complications of CF

Cystic fibrosis (CF) is the most commoln genetic disease seen among Caucasians in
the United States, affecting approximately 30,000 children and young adults (1). It is an
autosomal recessive disease where both parents must contribute the CF gene for it to be
manifest. One in 31 Americans is an asymptomatic carrier ofthe recessive CF gene (1).
The expected life span of patients with cystic fibrosis has more than tripled over the past
two decades going from median survival age of 10 years to median survival age of 32
years (2). Cystic fibrosis was once thought of as a childhood disease but has now carried
over into adulthood. Adult patients aged 18 years and older accounted for 37% of the CF
population in 1998 (2). With the extended life span of this population, long-term medical
complications secondary to this multifaceted disease have been manifest.
The Human Genome Project has made great strides in the research of genetic
diseases during the past 15 years, particularly with cystic fibrosis. The CF gene was the
first gene identified by the Human Genome Project, and it has been used as a paradigm for
the study of genetic diseases (3). This benchmark discovery has increased understanding
of the genetic basis of CF, the basis of the biochemical defect, and the pathophysiology of
the disease.
The cystic fibrosis transmembrane regulator (CFTR), a cyclic-AMP dependent
chloride channel, regulates the transport of chloride ions across the cell membrane
influencing water and electrolyte composition of sweat glands, pancreatic ducts,
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heptabiliary ducts, and gastrointestinal glands. A genetic mutation of the CFTR causes
faulty transport of sodium and chloride ions in the exocrine epithelial cells. This results in
an abnormal accumulation of a viscous, dehydrated mucous that obstructs the respiratory,
gastrointestinal, and genitouriniary tracts.
The primary clinical symptoms prior to diagnosis include respiratory distress,
failure to thrive, steatorrhea, meconium ileus, and an increase of chloride concentration in
the sweat. A sweat test result of sodium or chloride ion concentration greater than 60
mEq/L confirms diagnosis (4). The median age of diagnosis is 6 months and, and the
mean age of diagnosis is 3 years (2).
The prognosis of CF is largely dependent upon pulmonary status. A decrease in
Jung function contributes significantly to the complications and debilitating health seen in
CF. The obstruction of the airway epithelial cells results in bronchiolitis and increases
susceptibility to infections such as Pseudomonas aeruginosa that destroy the lung.
Seventy-six percent of the deaths reported to the Cystic Fibrosis Foundation Registry in
1998 were attributed to cardiorespiratory complications (2).
Another major complication of CF is pancreatic insufficiency. Pancreatic
insufficiency is found in approximately 85% of patients with CF, and a decrease in
pancreatic function is found in all patients with CF (2). Pancreatic secretions of water,
biocarbonate, and digestive enzymes decrease substantially causing malabsorption and
maldigestion of proteins, fats, and complex carbohydrates. A decrease in the production of
trypsin results in a reduction of the hydrolysis of proteins into peptides and amino acids,
and a decrease in the production of lipase results in a reduction of the hydrolysis of
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deficiency, approximately 93% of patients with CF use pancreatic enzyme replacement
therapy (2). Dosage of pancreatic supplements is determined on an individual basis due to
variation in diet, intestinal pH, and anatomy and physiology of the gastrointestinal tract.
As the disease progresses, more clinical manifestations related to nutrition decline
and deterioration of lung function present themselves. People with CF are at higher risk
for digital clubbing, nasal polyps, delayed onset of puberty, decline in growth, decreased
tolerance to exercise, liver disease, osteoporosis, pancreatitis, peptic ulcers, and diabetes.
Optimal nutrition has been found to prevent or delay the onset of these complications.

Nutrition Effects on CF
Malnutrition is a common complication of people with CF. According to the
Cystic Fibrosis Foundation 1998 Patient Registry, 22.5% of patients with CF fall below
the fifth percentile for weight and 17.9% fall below the 5th percentile for height (2).
Approximately 58% of those patients below the fifth percentile for weight have severely
compromised pulmonary function (2).
Improved nutritional status is positively correlated with increased longevity,
pulmonary status, growth, stature, and age- appropriate onset of puberty. Research
conducted on males with CF between the ages of 13 to 17 years at the Children's Hospital
of Pittsburgh Cystic Fibrosis Center identified nutrition and pulmonary function predictors
of delayed puberty. It was reported that adolescent males with CF were more likely to
have delayed puberty if they had weight::; 10th percentile (p<0.001), height::; 25th
percentile (p<0.05), or BMI::; 25th percentile compared to males with weight and height
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percentile (p<0.05), or BMI,::: 25th percentile compared to males with weight and height
greater than the 10th and 25th percentiles (5).
Another 3-year prospective study of growth, nutritional status, and body
composition in children with CF showed slower rates of growth in boys with CF
compared to boys without CF. Height for age z-scores (HAZ) decreased in children with
CF and remained constant in children without CF. Boys also gained less fat mass and less
fat-free mass than the controls. The authors concluded that children with CF grow at a
suboptimal rate (6).
The development of diabetes in patients with CF is also associated with
undernutrition. According to the CF Registry, 14.2% of the patients 18 years and older in
1998 had CF related diabetes (CFRD) that required insulin therapy (2). CFRD has similar
characteristics to type 1 and type 2 diabetes; however, it has unique factors related to CF
including undernutrition, chronic and acute infection, elevated energy expenditure,
glucagon deficiency, malabsorption, abnormal intestinal transit time, and liver dysfunction.
CFRD has been associated with increased malnutrition, increased pulmonary disease, and
earlier death. Therefore, achievement of optimal nutritional status through adequate
caloric intake and near-normalization of blood glucose levels are crucial in the nutritional
management ofCFRD.
Malabsorption can result in fat-soluble (A, D, E, K) vitamin deficiencies.
Fernachak at Denver prospectively evaluated the biochemical status of vitamins A, D, and
E in 127 infants diagnosed with CF through neonatal screening between January 1, 1984
and January 1, 1997 (7). Infants were treated with pancreatic enzymes and a daily
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multiple vitamin. Vitamin levels were monitored at yearly evaluations. During the initial
visit, a deficiency of 1 or more vitamins was present in 45.8% (44/96) of the patients.
Approximately 64% had a single vitamin deficiency, and 36.4% had multiple vitamin
deficiencies. Vitamin A and D deficiencies were typically corrected with supplementation
during the follow-up period, but vitamin E deficiency persisted despite supplementation.
Although a trend of higher fecal fat percentages was seen in those with a vitamin E
deficiency than those with a normal status, the difference was not statistically significant.
Alkaline phosphatase was the only liver function test to be significantly different between
the vitamin E deficient and normal status group. The authors hypothesized that people
with CF may require higher doses of vitamin E supplementation. However, compliance of
taking the vitamin supplements to c01Tect the deficiency may be a factor in deficiencies
and fat-soluble vitamin deficiencies occurring frequently in CF patients despite
supplementation. The authors concluded that this warrants routine monitoring of these
serum vitamin levels as recommended by the CF Foundation Consensus guidelines.
Since pancreatic insufficiency effects absorption, it has been hypothesized the
deficiency of the fat-soluble vitamins is related to the degree of pancreatic insufficiency. A
study of 252 subjects consisting of 210 CF patients and 42 CF-free control patients
compared serum levels of vitamin A and E (8). The CF patients were further subdivided
into pancreatic sufficient and pancreatic insufficient groups. The CF population had
significantly lower serum vitamin A and E levels (vitamin A p<0.002; vitamin E p<0.001)
than the control group. A significant difference between the control and both groups of
CF patients was seen for vitamin A levels (pancreatic sufficient p<O.O 1; pancreatic
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insufficient p<0.05). The only significant difference seen in vitamin E status was between
the control group and the pancreatic insufficient group(p<0.01). The authors concluded
that vitamin deficiency occurs despite pancreatic status.
Total energy needs are greatly increased for patients with CF, and it is not clear
what proportion is due to maldigestion and what proportion is due to increased energy for
breathing. Zemal and colleagues prospectively studied relationships among resting energy
expenditure (REE), growth, nutritional status, and pulmonary function in subjects
recruited from the CF Center at the Children's Hospital of Philadelphia (9). The best
predictors of REE included fat-free mass and height. Pulmonary function did not strongly
predict REE; however, percent ideal body weight predicted changes in pulmonary function
over time. The authors indicated that REE might be an indicator of the severity of the CF
independent of pulmonary function which confuses cause and effect.
The caloric needs of people with CF are approximately 120-150% of the RDA, yet
most patients do not meet these energy requirements through daily dietary intake.
Kawchak conducted a 3-year longitudinal, prospective study of dietary intake in
prepubertal, pancreatic-insufficient children with CF (10). Twenty-five children with CF
and 26 control children participated in the study. Energy and nutrient intakes calculated
from 3-day weighed food records were compared with CF recommendations,
recommended dietary allowance (RDA), and recommendations from the NHANES III.
Despite the fact that the children with CF consumed more energy than the control children
(p=0.025), they did not meet the CF recommended intakes of 120%RDA.
In another study on caloric needs of patients with CF, Horswill and colleagues
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found an increase in energy expenditure with subjects fed supplemental drinks (11).
Resting energy expenditure (REE) increased significantly in 8 subjects at The Hospital for
Sick Children, Toronto, Canada who received nocturnal elemental feedings via a
percutaneous endoscopic gastrostomy (PEG). No significant increase in protein turnover
was seen with nocturnal feeding. Their percent of weight per height improved
significantly from 74.5±7.7 before PEG placement to 88.0±7.0 (p<0.005) 1 year after
PEG placement. Fat body mass and fat-free body mass also significantly increased. No
significant changes occurred in pulmonary functions.
Since pulmonary and nutrition play an important role in optimizing the overall
treatment of CF, the Cystic Fibrosis Foundation Consensus Committee has provided
guidelines for nutritional assessment and intervention ( 10). The recommendations include
monitoring growth and nutritional status at routine visits every 3 to 4 months. Weight,
height, and head circumference until 2 years old are obtained and plotted on the growth
chart. These measurements are then used to calculate ideal weight for height and to assess
any significant changes. While many of the children may be at an appropriate weight for
height, they may not be growing at an adequate height velocity. If a child's parents are at
the 90 percentile for height and the child is only growing at the 25th percentile, he or she
is not receiving adequate nutrition to reach his or her potential genetic height. The
committee notes that particular attention needs to be paid to those children less than the
3rct percentile for height for possible stunting. Another part of the routine care includes
assessment of dietary intake. A patient may complete a 3-day food record or a calorie
count may be conducted when the patient is hospitalized which is often required annually.
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This provides information to assess the adequacy of caloric, vitamin, and mineral intake.
Malabsorption may impair growth and cause fat-soluble vitamin deficiencies. By
analyzing the amount of fat in a patient's feces gathered over three days, the degree of
malabsorption may be deteremined. Yearly complete blood count (CBC), serum albumin,
and serum or plasma retinol and a-tocopherol levels are recommended to monitor for
deficiencies and toxicities. The consensus committee has categorized nutritional
management into four modalities: routine management, anticipatory guidance, supportive
intervention, rehabilitative care, and resuscitative and palliative care. Routine nutritional
management includes fat-soluble vitamin supplementation and pancreatic-enzyme
replacement along with nutrition education and counseling. Patients with CF at risk for
developing energy imbalance but are maintaining weight-height index 2'._ 90% of ideal
weight fall into the anticipatory guidance category. Goals in this category include
education of increased energy needs, increase in caloric density of foods, increased
monitoring of dietary intake, and behavioral assessment and counseling. Patients whose
weight velocity decreases and/or weight-height index falls between 85 to 90% of ideal
weight require supportive intervention. This includes oral supplements with commercial
formulas such as Scandishakes, Pediasure, Carnation Instant Breakfast, and Boost. When
weight-height index becomes consistently below 85% of ideal weight and noninvassive
techniques have not been successful for 3 months, aggressive nutritional therapy should be
initiated. Naso gastric tubes, gastrostomy tubes, and jejunostomy tubes have been
successfully used methods for providing rehabilitative care. Progressive nutritional failure
and weight-height index <75% of ideal weight indicate need for resuscitative and palliative
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care which includes all of the other interventions and total parental nutrition.
Additional studies of PEG placement are warranted due to the potential benefit of
improved nutritional status and the associated decreased complications of CF. The
purpose of this research is 2-fold:
1) To determine the optimal time to place a percutaneous endoscopic gastrostomy
to achieve optimal nutritional status, lung function, and genetic growth potential.
2) To measure the barriers toward PEG tube placement for patients, parents, and
health professionals.
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CHAPTER II
PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (PEG) PLACEMENT TIME

Abstract

A retrospective chart review was conducted on pediatric patients at the
Intermountain Cystic Fibrosis Center who had a percutaneous endoscopic gastrostomy
(PEG) placed between 1993 and 1999. Height velocity in1proved significantly in the
group of patients with a PEG placed; however, pulmonary function declined more
significantly over time.

Introduction

Nutrition plays an integral role in survival of people with CF and has a strong
positive relationship with pulmonary status; therefore, intervention should be initiated
early in the course of the disease (I). Pulmonary status is measured by spirometry tests
which include, forced expiratory volume in 1 second after a full breath (FEV 1 ) and forced
vital capacity (FVC). Based on height, age, and gender, an expected value is generated.
Results are reported as percent of predicted FEV 1 and FVC. A direct association between
FEV 1, clinical status, and survival exists. Long-term nutritional supplementation via a
gastrostomy has been found to improve pulmonary and nutritional status; however, further
research is needed to determine the optimal time to initiate these supplemental feedings
and the attitudes toward initiation (1 ).
Levine (2) conducted a review of the literature to determine which CF patients are
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candidates for aggressive nutrition therapy. He first summarized some of the common
findings; 50% of CF patients are lower than the 10th percentile in height for age or weight
for age, and they have increased resting energy expenditure (REE) regardless of
pulmonary status. He concluded that since malnutrition is an important contributor to
morbidity and mortality in patients with CF, aggressive nutrition therapy should be
considered in any patient with CF at the first sign of deterioration in nutritional status and,
possibly, in pulmonary function. It was also recommended that more studies to determine
which patients are suitable candidates for nutritional therapy and when to initiate
nutritional supplementation be conducted, and that more effort must be made to
understand the increased REE in CF patients.
In a study to determine any potential benefits of supplemental feedings on
pulmonary function and growth in patients with CF, I 0 undernourished children aged 3 to
13.2 years were observed before and 1 to 2 years after enteral nutrition supplementation
(3). Seven of the patients received the nocturnal feedings through a gastrostomy tube.
Data on nutritional, clinical, and pulmonary status were collected at intervals one year
prior to the supplementation and 1 year during the supplementation. Changes in
pulmonary functions were compared with 14 other CF patients matched for sex, height,
and forced expiratory volume in 1 second (FEV 1 ). The study group experienced
significantly greater gains in weight and height than the control group. Pulmonary decline
decreased significantly in the study group along with the number of pulmonary
exacerbations per year.
In a 5-year follow-up study to determine the effect of aggressive nutrition support
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on growth and pulmonary function in the short and long term, undernourished children
with CF were matched according to height, pulmonary function, and sex (4). One group
received supplements for a median of 1.35 years. The supplemental group had lower
mortality and significantly higher height and weight z scores at 4 and 5 years. The slope
for declining pulmonary function was significantly smaller at 3 years for the supplemented
group, and no difference was seen after 5 years. Since the improvement continued after
supplementation was discontinued, the authors suggested that supplementation for periods
longer than 1 year may produce greater gains and prolong the improvement in pulmonary
function.
Long-term placement of gastrostomy tube feedings have also been studied to
determine if there are benefits in lung function with supplemental nutrition. Walker and
Goza! (1) followed the pulmonary function of CF patients for 2 years after the placement
of a percutaneous endoscopic (PEG) tube. The criteria for a PEG tube placement was the
patient ' s weight lower than 85% ideal weight for height, weight loss for more than 2
months, and plateau in weight gain for 6 months. After PEG placement, nutritional and
pulmonary status were followed for 2 years. The authors concluded that long-term
nutritional benefit of PEG placement is critically dependent on presurgical pulmonary
function. They suggested that PEG placement be considered an early intervention rather
than one of last resort.
An additional study of the effect of nocturnal tube feedings on pulmonary function

was conducted at Children's Hospital in Hannover Germany by Steinkamp and Horst von
der Hardt (5). They reported that nocturnal PEG feedings of malnourished patients with
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CF improved nutritional and pulmonary status. Fourteen patients who received
supplemental nocturnal feedings via a PEG were followed 26 months. The weight for
height was 77.8% at time of initiation and improved by 9% one year after placement.
Lung functions improved significantly between initial placement and one year.
It has been concluded that PEGs improve growth and nutrition status in patients
with CF. Earlier placement of PEG, before declining to 85% ideal body weight, may have
additional benefits. The purpose of this study was to determine the optimal time to place a
percutaneous endoscopic gastrostomy to achieve optimal nutritional status, lung function,
and genetic growth potential.

Methods

Population

The Intermountain Cystic Fibrosis Center consisted of the adult center at the
University of Utah Hospital and the pediatric center at Primary Children's Medical Center
in Salt Lake City, Utah. Approximately 250 patients were seen at this center, and of this
population, 22 pediatric patients and I 0 adult patients had a gastrostomy placed between
1993 and 1999. The 22 pediatric patients and a matched-control were selected for the
study.

Study design

Medical charts at the Intermountain Cystic Fibrosis Center were retrospectively
reviewed for pulmonary and anthropometric parameters of the CF patients. Data was
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collected on the pulmonary and anthropometric indices that led to gastrostomy placement
in the patients with a PEG and the effects on pulmonary function and growth 12 months
after PEG placement. These patients were then matched with patients without a PEG
based on pulmonary status, age, and gender at time of PEG placement. Height, weight,
FEV 1, and FVC, of the PEG and non-PEG patients were obtained and analyzed for
differences.

Data Management and Statistical Analysis

Results of pulmonary function tests were collected for 1 month prior to placement,
1 month after PEG placement, and 3 non-sick measurements within 24 months after PEG
placement. Independent t-tests were used to measure differences in weight, height, and
pulmonary functions over time. A paired t-test was conducted between the non-PEG
controls matched with the patients with PEGs to determine if PEG placement improves
nutritional and pulmonary status.

Results

Short-term pulmonary function tests, those measurements taken I month after
PEG placement, declined significantly. FVC% predicted fell from 68±19 to 59±16
(p=0.014), and FEV 1 fell from 56±21 to 49±15 (p=0.02). Long-term data, average of 3
non-sick measurements within 24 months of PEG placement excluding short-term data,
showed a significant decrease in pulmonary function. The mean% predicted FVC and
FEV 1 were 8.6% (p=0.034) and 8.2% (p=0.02) lower following PEG placement. The
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PEG group had improved height velocity compared to the non-PEG group (p=0.048).
However, the PEG group had significantly greater declines in pulmonary function over
time.
Discussion

PEG placement was shown to improve nutritional status; however, it is somewhat
controversial as to whether or not it improves pulmonary function. The CF Consensus
Committee recommends initiation of gastrostomy placement based on percent ideal weight
for height being less than 85% or a plateau in weight gain for 3 months (6). Yet, PEGs
were placed in patients greater than 85% of ideal weight for height. Due to the small
number of gastrostomies placed in people with CF, it is difficult to statistically verify the
benefits of earlier placement. Patients with decreased pulmonary status do not do as well
with PEG placement secondary to the need to be able to withstand an initial decline in
pulmonary functions immediately following PEG placement. Further multi-center studies
need to be conducted to determine the nutritional and pulmonary effects of earlier
placement.
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CHAPTER III
QUESTIONNAIRE REGARDING ATTITUDES OF PEOPLE WITH CYSTIC
FIBROSIS TOWARD PERCUTANEOUS ENDOSCOPIC
GASTROSTOMY PLACEMENT

Abstract

A PEG and non-PEG questionnaire was developed to identify concerns toward
PEG placement. Questionnaires were mailed to patients seen in accredited cystic fibrosis
centers in Arizona, Colorado, Idaho, Montana, Nevada, and Utah. For patients 10 to 18
years old, separate questionnaires linked by identification number were sent to the parent
and child. The response rate for the PEG questionnaire was 54.25% and for the non-PEG
questionnaire was 24%. Ninety-six percent of the patients with a PEG reported that
weight was a problem at time of PEG placement, and 91 % reported weight gain after PEG
placement. SD..rty-four percent of patients with a PEG would have a PEG placed if they
had to make the decision of whether or not to place it again. Sixty-one percent of patients
thought a PEG would look bad, and 59.4% would be embarrassed to have a PEG. A lack
of knowledge of PEG tubes was expressed by 49.3% of the patients, and 35.4% had no
opinion regarding their knowledge of PEG tubes. A lack of knowledge regarding PEG
tubes exists amongst the CF population.

Introduction

Nutrition plays a vital role in the complex treatment regimen of cystic fibrosis
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(CF). Inadequate weight gain and malnutrition in people with CF have been shown to be
highly correlated with pulmonary decline, osteoporosis, and delayed puberty. Due to the
nutritional complications of CF, extra emphasis is placed on nutrition. Therefore, many
patients with CF have challenges with eating patterns and behaviors. Mealtime frequently
becomes a battleground between children expressing autonomy and parents trying to
provide adequate nutrition. Stark and colleagues found that children with CF when
compared to children without CF talked more, spent more time away from the table,
refused more food, and were more noncompliant in response to commands to eat.
Regardless of whether or not a child had CF, if he or she spent longer than 20 minutes at
dinner, he or she consumed a lower percent of the RDA (92% vs 97%) and fell into a
lower weight percentile compared to children who spent less than 20 minutes at dinner
(1). The symptoms of CF may include foul-smelling, oily stool and abdominal distress

secondary to malabsorption and maldigestion of nutrients. In order to diminish or
eliminate these symptoms, many children with CF refuse to eat. The aforementioned
complications of eating increase the frustration of people with CF trying to consume 120150% of the RDA. To alleviate the eating battle, or simply to increase the caloric intake
of people with CF, gastrostomy placement has been recommended.
The decision to use a percutaneous endoscopic gastrostomy (PEG) for long-term
nutritional support involves several variables. The level of family involvement and
commitment influences the success of PEG placement as a means of nutritional support
and factors into the decision-making process. Physicians' opinions on PEG placement
also influence the decision. Van Rosendaal and colleagues (2) studied the decision making
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process in determining whether or not to place a PEG. They found that physicians and
family members input had the greatest impact on the process. According to an Australian
study of adolescents with CF, family members provided more tangible support. This
included reminders to perform treatment tasks, helping out with treatment tasks, or
actually doing treatment tasks (3). This same study also looked at the support friends
gave to the adolescents with CF. It showed that friends provided more emotional support,
which related to acceptance of CF; however, 20% of these adolescents expressed concerns
about disclosing to their friends that they had CF (3).
The daily treatment regimen for people with CF involves of myriad of tasks which
include chest physiotherapy, use of inhalant medications, high-calorie diets, pancreatic
enzymes, and vitamin supplements. All of these tasks prove to be time-consuming and
stressful on the parent-child relationship; yet, compliance significantly influences life
expectancy. Eddy and colleagues (4) looked at marital adjustment, family characteristics,
and parent-child stress in relationship to compliance. Parents with lower stress reported
better compliance with dietary and nutritional therapies. These multiple psychosocial
factors support the CF Foundation Consensus Committee's recommendation of family
assessment and education regarding enteral nutrition prior to initiation (5).
Eating not only serves the purpose of providing calories and nutrients for an
individual, but it also involves manifold psychological factors. Therefore, the decision to
use long-term gastrostomy feedings takes on multiple meanings. Some may view
placement as giving up hope and a sign that the disease is getting worse. If the family has
experienced continuous battles over food and lengthy mealtimes as seen in patients with
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CF, gastrostomy placement may be seen as a welcome relief Some patients and parents
may view gastrostomy placement as failure to take good care of the person. Whatever the
meaning may be for each person deciding whether or not to place a gastrostomy, the
person's individual needs deserve respect (6).
Long-term gastrostomy feedings appear to be a safe and effective means of
improving nutrition status of malnourished CF patients as determined in a longitudinal,
retrospective study conducted by Rosenfeld and colleagues (7). In this study weight
percentile for age and weight as a percentage of ideal body weight improved significantly
6 to 18 months after placement of the gastrostomy (an increase from the 2"ct percentile
weight to the 12 111 percentile weight or, 88% ideal body weight to 90% ideal body weight).
Height percentile increased significantly 18 to 30 months after placement of gastrostomy
from the 6th percentile for height to the I 0th percentile for height. Weight continued to
improve to 93% ideal body weight 18 to 30 months after placement.
According to the 1998 Cystic Fibrosis Foundation Patient Registry for Centers in
Utah, Arizona, Colorado, and New Mexico, 8.73% of the patients had a gastrostomy at
that time (8). It was also reported that 14.16% of the children and 21.20% of the adults
fell below 85% of ideal body weight (IBW). The CFF Consensus Committee
recommended aggressive nutritional therapy such as percutaneous endoscopic
gastrostomy (PEG) when IBW falls below 85% indicating 5.43% to 12.77% of patients
with CF were not receiving the recommended treatment (5, 8). Despite the known
benefits of PEG placement, patients refuse this nutritional therapy. The purpose of this
study was to better understand patient and family attitudes toward PEG placement.
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Methods
Population

The population for this study was selected from the following accredited cystic
fibrosis centers: The Children's Hospital (pediatric) and University of Colorado Health
Sciences Center (adult), Denver, Colorado and its affiliate in Billings, Montana; Tucson
Cystic Fibrosis Center, University of Arizona Health Sciences Center, Tucson, Arizona;
and Intermountain Cystic Fibrosis Center which included Primary Children' s Medical
Center (pediatric) and University of Utah School of Medicine (adult) in Salt Lake City,
Utah; Pocatello Children and Adolescent Clinic, Pocatello, Idaho; and Cystic Fibrosis
Affiliate Program, Meridian, Idaho. These CF centers enrolled patients from the states of
Arizona, Colorado, Idaho, Montana, Nebraska, Nevada, Utah, and Wyoming representing
people from urban and rural areas. Patients aged 10 years and older and parents of
children aged 0 to 18 years old who attended these accredited CF centers were invited to
participate in the study. This age was decided upon based on the reading level of the
questionnaire as dictated by Primary Children's Medical Center's IRB.

Questionnaires

Researchers at the Intermountain CF Center developed a pilot questionnaire for
patients with a PEG that identified concerns patients and families had toward PEG
placement. This information was used to develop 4 corresponding questionnaires for: 1)
patients aged 10 years and older with a PEG (Appendix G); 2) parents of children aged 0
to 18 years with a PEG (Appendix H); 3) patients aged 10 years and older without a PEG
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(Appendix E); 4) parents of children aged 0 to 18 years without a PEG (Appendix F).
The questionnaires for the children and parents differed only in first and second person
format. Content validity was established by physicians, nurses, social workers, and
dietitians who worked with the CF population.
The questionnaires included a self-reported age, weight, height, number of days
hospitalized within the last year, health in last year, and activity level in past year. The
next section consisted of statements regarding PEG placement each followed by a 5category Likert scale (1 =strongly agree, 2=agree, 3=no opinion, 4=disagree, S=strongly
disagree).
A follow-up questionnaire similar to the questionnaires for patients with CF was
sent to professionals working with the CF population in Tucson, Arizona; Denver,
Colorado; Albuquerque, New Mexico ; and Salt Lake City, Utah, to determine their
attitudes toward PEG placement (Appendices I, J).

Data Management and Collection

The institutional review boards from Utah State University; The Children' s
Hospital, University of Colorado Health Sciences Center, Denver, Colorado; University of
Arizona, Tucson, Arizona; and University of Utah and Primary Children' s Medical Center,
Salt Lake City, Utah; approved the study. A cover letter described the purpose of the
study, invited the patients and/or parents to participate, and assured confidentiality
(Appendices A, B, C). The packet for the non-PEG questionnaires included an
explanation and illustration of a gastrostomy (Appendix D). Non-PEG and PEG
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questionnaire packets were mailed to all patients and/or their parents attending the
aforementioned CF centers, except Tucson, Arizona. Participants from Tucson, Arizona
completed the non-PEG questionnaire during a routine clinic visit, and the PEG
questionnaires were mailed to all patients and/or parents. For patients between the ages of
10 to 18 years, the parents and children were sent separate questionnaires linked by an
identification number for comparison of parent and children's attitudes toward PEG
placement. A reminder PEG-questionnaire was sent to potential participants 3 months
after the original one was distributed. Participants anonymously completed and returned
the questionnaire to Primary Children' s Medical Center in a prepaid self-addressed
envelope.

Data Management and Statistical Analysis

All data were collected and entered into SPSS™ for statistical analysis. Descriptive
statistics were used to report age, gender, days hospitalized in past year, overall health and
activity in the past year, and responses to the statements regarding PEG placement.
Pearson correlation coefficients were conducted to determine relationships between
responses. Alpha reliability analysis measured internal consistency of the questionnaire.
Paired t-tests were used to determine if parent's and children's responses differed from
each other. An independent t-test was used to identify differences between attitudes
toward PEG placement of people without a PEG and people with a PEG.
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Results

PEG Questionnaire

Questionnaires were returned from the states of Utah, Arizona, Colorado,
Montana, and Idaho. The overall response rate for the PEG questionnaire was 54.25%
(51/94). Thirty-six individual patients were identified amongst the 51 completed
questionnaires. Of the 36 individuals, 15 of them had dual representation secondary to
parent and child completing separate questionnaires for the same individual.
Seventy-two percent (26/36) of the individual patients were female, and the mean
age was 12 7/ 12 years ranging between the ages of2 10/ 12 years to 26 years old. Patients
were reported to have been hospitalized an average of 15.12 days in the past year ranging
from O days to 70 days. The median response for perceived health in the past year was
reported as good, and the median response for activity level compared to peers was
reported to be about the same as peers. Table 1 shows the mean and median response to
the statements found in the PEG questionnaires.
Ninety-three percent of the parents and 96% of the patients reported that weight
was a problem at the time of PEG placement. After PEG placement, 91 % of the patients
reported weight gain; 73% said the PEG had helped them grow; 59% reported to have
more energy; and 77% reported they were healthier after PEG placement. When asked
whether or not they would have a PEG placed if they made the decision again, 79% of the
parents and 64% of the patients said they would have the PEG placed. Tables 2 and 3
show the frequency of responses to the statements on the questionnaire.
The results of Pearson correlations between variables on the questionnaire are
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reported in Table 4. If a respondent felt the PEG interfered with sports and other
activities, he or she most likely felt that a PEG looked bad and was embarrassing. Weight
gain was usually reported with a report of the PEG helping the patient grow. Those
respondents who thought the PEG looked bad, was embarrassing, and hurt were more
likely not have a PEG placed if they had to decide whether or not to place it again.
According to a paired t-test, children ages 10 to 18 years responded significantly
different from their parents in the rating of overall health in the past year (p=0.04); status
oflungs before PEG placement (p=0.04); and if the PEG looked bad (p=0.02). Children
reported their health better than their parents, and they also said their lungs were not as
healthy prior to PEG placement. In response to the statement that a PEG looks bad, the
children had no opinion while the parents disagreed that the PEG looked bad. No other
significant differences were found between parents and children.

Non-PEG Questionnaire

Questionnaires were returned from the states of Arizona, Colorado, Idaho,
Montana, Nebraska, Nevada, Utah, and Wyoming. The response rate for the non- PEG
was 24% (248/1030). This does not include ten questionnaires that were completed in
clinic and returned from Arizona. Two-hundred three patients were identified amongst the
248 completed questionnaires. Of the 203 individuals, 45 of them had dual representation
secondary to parent and child completing separate questionnaires for the same individual.
Fifty-one percent (104/203) of the patients without a PEG were male, and 49% (99/203)
were female. The mean age for the non-PEG patients was 16 years with a range of0.5
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Table 1 Mean and Standard Deviation/Median Response to PEG Questionnaires
Statement

Mean/Median
Response
All patients*

Mean/Median
Response
Parents**

2.69±1.26
2.85:!) .22
2.00
2.00
n=29
n=35
1.41±0.73
l.47:!::(l.74
My weight was a problem
1.00
1.00
when the PEG was placed
n=29
n=36
4.00±1.31
3.75±1.38
I ate enough before my PEG
4.00
4.00
was placed.
n=29
n=36
1.55±0.87
1.58±0.84
I have gained weight with my
1.00
1.00
PEG.
n=29
n=36
3.41±1.21
3.44±1.23
I thought that getting a PEG
4.00
3.50
meant my CF was getting
n=29
n=36
worse.
3.21±1.29
3.36±1.29
My PEG makes it hard to do
4.00
4.00
sports or other activities.
n=29
n=36
3.90±0.90
3.33±1.33
I think my PEG looks bad.
4.00
4.00
n=29
n=36
3.48±1.18
3.5 8±1.23
I would be embarrassed if my
4.00
4.00
friends knew I had a PEG.
n=29
n=36
3.79±1.01
3.83± I.I I
My PEG hurts.
4.00
4.00
n=2 9
n=36
3.07±1.56
3.31±1.55
My family has trouble buying
4.00
4.00
the formula.
n=29
n=3 6
l .66:!::(l.94
I 92±0.94
The PEG bas helped me grow
1.00
2.00
taller, gain weight, and/or
n=29
n=36
develop puberty.
2.55±0 .95
2.86±0 .88
The PEG has helped my
3.00
3.00
lungs.
n=29
n=36
2.34±1.20
2.50±1.16
I have more energy with my
2.00
2.00
PEG.
n=29
n=36
1.76±0.79
1.89±1.01
I am healthier now after the
2.00
2.00
PEG.
n=29
n=36
4.10±1.29
3.89±1.35
If I could do it over again, I
5.00
4.00
would NOT have a PEG.
n=29
n=36
Response Key: I =strongly agree, 2=agree, 3=no opinion, 4=disagree, 5=strongly disagree
* N includes all patients and parents where a child did not respond.
** N includes all parents of patients 0 to 18 years of age
••• N includes all patients I 0 years and older
When my PEG was placed, I
bad healthy lungs.

Mean/Median
Response
Patients***
2.81±1.21
2.00
n=21
l.36±0.58
1.00
n=22
3.45±1.50
4.00
n=22
1.55±0.80
1.00
n=22
3.22±1.31
3.00
n=22
3.36±1 .40
4.00
n=22
2.86±1.42
3.00
n=22
3.45±1.37
4.00
n=22
3.68±1.32
4.00
n=22
3.45±1.63
4.00
n=22
2.05±0.95
2.00
n=22
3 05±0 86
3.00
n=2 1
2.55± I. I 0
2.00
n=22
1.95±1.09
2.00
n=22
3.64±1.47
4.00
n=22
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Table 2 Freg,uencies of Parents' ResEonses to PEG Questionnaire
Strongly
Agree

Agree

No
Opinion

Disagree

Strongly
Disagree

When my child's PEG tube was placed,
be or she had healthy lungs. (n=29)

13 .8%

44.8%

10.3%

20.7%

10.3%

My child's weight was a problem when
the PEG was placed. (n=29)

69%

24 .1%

3.4%

3.4%

0%

My child ate enough before his or her
PEG was placed. (n=29)

6.9%

13 .8%

0%

31%

48.3%

My child bas gained weight with his or
her PEG. (n=29)

62.1%

27.6%

3.4%

6.9%

0%

I thought that getting a PEG meant my
child's CF was getting worse. (n=29)

6.9%

20.7%

13.8%

41.4%

17.2%

My child's PEG makes it bard for him
or her to do sports or other activities.
(o=29)

10.3%

27.6%

6.9%

41.4%

13 .8%

0%

138%

3.4%

62.1%

20.7%

My child would be embarrassed if his
or her friends knew he or she had a
PEG. (n=29)

6.9%

17.2%

13 .8%

44.8%

17.2%

My child's PEG is painful. (n=29)

3.4%

10.3%

10.3%

55.2%

20.7%

We have difficulty affording tbe
formula. (n=29)

27.6%

10.3%

10.3%

31%

20.7%

The PEG has helped my child grow
taller, gain weight, and/or develop
puberty. (n=29)

58.6%

24.1%

10.3%

6.9%

0%

The PEG has helped my child's lungs.
(n=29)

17 .2%

24.1%

44.8%

13.8%

0%

My child has more energy with his or
her PEG. (n=29)

31%

27.6%

20.7%

17.2%

3.4%

My child is healthier now after the
PEG. (n=29)

41.4 %

44.8%

10.3%

3.4%

0%

If I could do it over again, my child
would NOT have a PEG. (n=29)

6.9%

10.3%

3.4%

24.1%

55.2%

Statement

My child's PEG looks bad. (n=29)
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Table 3 Fre9uencies of Patients' Responses to PEG Questionnaire
Strongly
Agree

Agree

No
Opinion

Disagree

Strongly
Disagree

When my PEG tube was placed,
I had healthy lungs. (n=2 I)

9.50%

42.90%

14.30%

23.80%

9.50%

My weight was a problem when
the PEG was placed. (n=22)

68 .20%

27.30%

4.50%

0.00%

0.00%

I ate enough before my PEG
was placed. (n=22)

13.60%

22.70%

0.00%

31.80%

31 .80%

I have gained weight with my
PEG. (n=22)

63.60%

27.30%

4.50%

4.50%

0.00%

I thought that getting a PEG
meant my CF was getting
worse. (n=22)

9.10%

22.70%

27.30%

18.20%

22.70%

My PEG makes it hard to do
sports or other activities. ( n=22)

9.10%

27.30%

4.50%

36.40%

22.70%

I think my PEG looks bad.
(n=22)

22.70%

22.70%

13.60%

27.30%

13 .60%

I would be embarrassed if my
friends knew I had a PEG.
(n=22)

13 .60%

13.60%

9.10%

40.90%

22.70%

My PEG hurts. (n=22)

9.10%

13.60%

9.10%

36.40%

31 .80%

My family has trouble buying
the formula. (n=22)

22 .70%

9.10%

4.50%

27 .30%

36.40%

The PEG has helped me grow
taller, gain weight, and/or
develop puberty. ( n=22)

31.80%

40.90%

18.20%

9.10%

0.00%

The PEG has helped my lungs.
(n=21)

0.00%

28 .60%

42 .90%

23.80%

4.80%

I have more energy with my
PEG. (n=22)

13.60%

45.50%

18.20%

18.20%

4.50%

I am healthier now after the
PEG. (n=22)

40.90%

36.40%

13 .60%

4.50%

4.50%

Ifl could do it over again, I
would NOT have a PEG .
(n=22)

18.20%

0.00%

18.20%

27.20%

36.40%

Statement
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Table 4 PEG Questionnaire Pearson Correlations
Variables
age x days hospitalized
age x health
age x activity
age x looks
age x embarrass
age x pay
age x healthier
gender x activity
gender x sports
days hospitalized x health
days hospitalized x activity
days hospitalized x healthy
lungs
days hospitalized x looks
days hospitalized x healthier
health x activity
health x healthy lungs
health x looks
activity x healthy lungs
activity x weight problem
activity x pay
activity x healthier
healthy lungs x gained
healthy lungs x hurts
healthy lungs x grow
healthy lungs x healthier
healthy lungs x not again
weight problem x ate enough
ate enough x not again
gained x hurts
gained x grow
gained x energy
gained x healthier
gained x not again
sports x looks
sports x embarrass
sports x pay
sports x not again
looks x embarrass
looks x pay
looks x not again
embarrass x hurts
embarrass x pay
embarrass x not again
hurts x pay
hurts x energy
hurts x healthier
hurts x not again
pay x not again
grow x helped lungs
grow x energy
grow x healthier
grow x not again
energy x healthier
helped lungs x energy
helped lungs x healthier
healthier x not again

All Patients

Parents Only

Patients Only

0.518** (n=33)
-0.516** (n=34)
-0.656** (n=33)
-0.424* (n=35)
0.195 (n=35)
0.460** (n=35)
0.371 * (n=35)
-0.461 •• (n=34)
0.322 (n=36)
-0.527** (n=34)
-0.4 73 **(n=33)
0.197 (n=33)

0.465*(n=26)
-0.3 10 (n=28)
-0.482**(n=28)
-0.277 (n=28)
0.010 (n=28)
0.381 * (n=28)
-0.051 (n=28)
-0.298 (n=29)
0.285 (n=29)
-0.511 ** (n=27)
-0.413* (n=27)
0.420*(n=27)

0.403 (n=20)
-0.549** (n=2 l)
-0.638**(n=20)
-0 099 (n=22)
0.429* (n=22)
0.419 (n=22)
0.553** (n=22)
-0.588**(n=20)
0.473*(n=22)
-0.547* (n=20)
-0.495* (n=l9)
0.1 89 (n=l9)

-0.572** (n=34)
0.383* (n=34)
0.691 •• (n=34)
-0.379* (n=34)
0.408* (n=35)
-0.184 (n=33)
0.392* (n=34)
-0.295 (n=34)
-0.330 (n=34)
-0.371 * (n=35)
0.433** (n=35)
-0.369* (n=35)
-0.369* (n=35)
0.380* (n=35)
-0.414* (n=36)
0.353* (n=36)
-0.291 (n=36)
0.5 71 ** (n=36)
0.308 (n=36)
0.382* (n=36)
-0.319 (n=36)
0.51
(n=36)
0.458** (n=36)
0.430**(n=36)
0.369* (n=36)
0.420* (n=36)
0.227 (n=36)
0.483** (n=36)
0.199 (n=36)
0.340* (n=36)
0.507** (n=36)
0.231 (n=36)
-0.334* (n=36)
-0.375* (n=36)
0.542** (n=36)
0.250 (n=36)
0.204 (n=36)
0.276 (n=36)
0.625** (n=36)
--0.4 l 5*(n=36)
0.563** (n=36)
0.459** (n=35)
0.317 (n=35)
--0.430* (n=36)

-0.237 (n=27)
-0.025 (n=27)
0.649** (n=29)
-0.159 (n=29)
0.272 (n=29)
-0.081 (n=29)
0.466* (n=29)
--0.046 (n=29)
0.025 (n=29)
-0.263 (n=29)
0.509** (n=29)
-0.276 (n=29)
-0.440* (n=29)
0.461 * (n=29)
--0.372* (n=29)
0.465* (n=29)
-0.474** (n=29)
0.681 ** (n=29)
0.426* (n=29)
0.620** (n=29)
-0.562** (n=29)
0.357 (n=29)
0.493** (n=29)
0.277 (n=29)
0.393* (n=29)
0.384* (n=29)
0.133 (n=29)
0.3 17 (n=29)
0.443* (n=29)
0.349 (n=29)
0.597** (n=29)
0.485** (n=29)
-0.262 (n=29)
-0.423* (n=29)
0.645** (n=29)
0.387* (n=29)
0.504** (n=29)
0.490** (n=29)
0.659** (n=29)
--0.560** (n=29)
0.620** (n=29)
0.547* (n=29)
0.377* (n=29)
--0.608** (n=29)

-0.457* (n=20)
0.464* (n=20)
0.701 ** (n=20)
-0.708** (n=20)
0.354 (n=21)
-0.537* (n=l9)
0.108 (n=20)
-0.448* (n=20)
-0.452* (n=20)
--0.503* (n=2l)
0.540* (n=2 l)
-0.334 (n=2 I)
-0.227 (n=2 l)
0.430 (n=2 l)
-0.416 (n=22)
0.273 (n=22)
-0.381 (n=22)
0.594•• (n=22)
0.270 (n=22)
0.300 (n=22)
-0.284 (n=22)
0.762** (n=22)
0.391 (n=22)
0.566** (n=22)
0.427* (n=22)
0.521 * (n=22)
0.522* (n=22)
0.591 ** (n=22)
0.110 (n=22)
0.416 (n=22)
0.466* (n=22)
0.203 (n=22)
-0.398 (n=22)
-0.407 (n=22)
0.527* (n=22)
0.433* (n=22)
-0.006 (n=2 l)
0.203 (n=22)
0.646** (n=22)
-0.398 (n=22)
0.537** (n=22)
0.452* (n=2l)
0.317 (n=21)
--0.339 (n=22)

o••

*Correlation is significant at the 0.05 level (2-taiJed)
**Correlation is significant at the 0.0 l level (2-tailed)
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year to 52 years of age. Self-reported days hospitalized ranged from 0 to 105 days with a
mean of 7.28±15.36 days. Seventy-seven percent of the patients' overall health in the past
year was reported as either good or very good with 51 % reporting activity level equal to
peers. Only 10% of the people without a PEG reported that a member of the CF health
care team had recommended PEG placement. Table 5 reports the mean and median
responses for the non-PEG questionnaire.
Of those patients without a PEG, 55% either disagreed or strongly disagreed that
their weight was a problem; 64% either disagreed or strongly disagreed that they did not
want to gain weight; and 68% thought they ate enough. Fifty-three percent thought a
PEG would look bad, and 55% would be embarrassed to have a PEG. Getting a PEG
meant the CF was getting worse to 55.4% of the patients. A lack of knowledge
concerning PEG tubes was expressed for 61 % of the patients with 20.3% having no
opinion as to whether or not they knew enough about the pros and cons of PEG
placement. Tables 6 and 7 report the frequency ofresponses to the statements on the nonPEG questionnaire.
According to a paired t-test, children ages 10 to 18 years and their parents
responded highly significantly different to whether a PEG would limit participation in
sports and other activities (p=0.000); significantly different to if a PEG would be painful
(p=0.02); ifa child would have a PEG placed ifhe or she was losing weight (p=0.012);
and a nasogastric (NG) tube would be preferred if nutrition support was indicated
(p=0.044). The children felt it would be harder to participate in sports or other activities
with a PEG than their parents. They also thought a PEG would be more painful. If their
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Table 5 Non-PEG Questionnaire Mean and Standard Deviation/ Median Responses
Statement
My weight is a problem.

I don 't want to gain weight.

My family or friends think I
don't eat enough.
CF patients with lung problems
need a PEG.
CF patients with no lung
problems do not need a PEG.
It would be hard to do sports or
other activities with a PEG.

A PEG looks bad.

A PEG would embarrass me.

A PEG would hurt.

Getting a PEG means my CF is
getting worse.
My insurance/HMO/Medicaid
would pay for the formula used in
PEG feedings.
A PEG would help me row
taller, gain weight, or evelop
puberty.

Mean/Median
Response
All patients
3.30±:1.29
400
n=202
3.65:!:1.21
4.00
n=202
3.67±:1.16
4.00
n=202
3.43±:0.83
3.00
n=200
3.14±:0.80
3.00
n=201
2 73±:0.96
3.00
n=201
2.53±:0.97
2.00
n=202
2.44:!:1.06
2.00
n=202
2.76±:0.88
3.00
n=201
2.58±:1.05
2.00
n=202
2.89±:0 86
3.00
n=200
2.75+0.87
3:00
n=201

Mean/Median Response
Parents
3.41:!:1.32
400
n=l25
3.83±:1.04
4 .00
n=l25
3 66:!:1.l 7
4.00
n= l25
3.41 ±:0.87
3.00
n= 123
3.14:!:0.81
3.00
n=l25
2.92±:0.94
3.00
n=l25
2.70±:0.95
3.00
n=l2 5
2.48:!: 1.02
2.00
n= J25
2.80±:0.88
3.00
n=124
2.68::tl .06
3.00
n= J25
2.98:t0.84
3.00
n= l23
2.76+0.89

Mean/Median
Response
Patients
3.34:!:1.26
400
n=120
3.40±:1.44
4.00
n=121
3.63:!:) . l I
4.00
n=l2 1
3.48:!:0.8 I
3.00
n= l21
3 01±:0.84
3.00
n=l 19
2.38±:0.97
2.00
n=l 19
2.30±:0.93
2.00
n=121
2.32±:1.07
2.00
n= l21
2.62+0.97
3:00
n=l21
2.55:!::1.04
2.00
n= 121
2.78:!:0 87
3.00
n= l20
2.74+0.80

n= l25

n= 120

mo

mo

A PEG may help my lungs.

3.04+0.89

mo

n=201

3.09+0.90
3:00
n=l25

3.06+0.93
3:00
n=l20

A PEG may give me more energy.

2.68+0.87
3:00
n=200

2.74+0.87
3:00
n=l24

2.63+0.88

If I was losing weight, I would
want a PEG.

2.92+1.04

mo

n=201

2.68+0.94
3:00
n=l25

3.2 1+1.14
3:00
n=120

I know enough about theJood
and bad things about PE tubes.

3.61+1.13
4:00
n=202

3.63+1. 17
4:00
n=l25

3.46+1.0l

If my a~tetite got worse, I would
want a
G.

3.03+0.99
3:00
n=20 1

2.88+0.92

3.24+1.03
3:00
n=l21

mo

n=124

3.41+1.12
3.51+1.05
If I needed extra nutrition, I
3:00
3:00
would prefer a nasogastric (NG)
n=125
n=201
tube.
Response Key: I =strongly agree, 2=agree, 3=no opinion, 4=disagree, 5=strongly disagree
• N includes all patients and parents where a child did not respond.
•• N includes all parents of patients 0 to 18 years ofage
••• N includes all patients I 0 years and older

mo

n=l20

mo

n= l21

3.42+1. l 9
3:00
n=l20
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Table 6 Frequencies of Patients' Responses to Non-PEG Questionnaire
Strongly
Agree

Agree

No
Opinion

Disagree

Strongly
Disagree

My weight is a problem. (n=129)

7.00%

27.10%

13.20%

32.60%

20.20%

I don't want to gain weight.
(n=l30)

13.10%

20.80%

7.70%

27.70%

30.80%

MJ family or friends think I don't
eat enough. (o=l30)

0.80%

22.30%

14.60%

36.90%

25.40%

CF patients with lung problems
netd a PEG.(o=l30)

1.50%

4.60%

48.50%

35.40%

10.00%

CF patients with no lung problems
do not need a PEG. (n=l27)

4.70%

15.70%

54.30%

22.00%

3.10%

It would be hard to do sports or
other activities with a
PEG.(o=l28)

15.60%

43 .00%

26.60%

l l.70%

3.10%

A PEG looks bad.(o=130)

19.20%

41.50%

28.50%

10.80%

0.00%

A PEG would embarrass
me.(o=l30)

23.80%

35.40%

26.20%

12.30%

2.30%

A J>EG would hurl(n=l30)

14.60%

24 .60%

44 .60%

13.80%

2.30%

Getting a PEG means my CF is
getting worse. (o=l30)

12.30%

43.80%

19.20%

22.30%

2.30%

insurance/HMO/Medicaid
pay for the formula used in
PEG feedings. (n=l28)

7.00%

26.60%

53.10%

7.80%

5.50%

A PEG would help me grow taller,
gain weight, or develop puberty.
(n=l29)

3.90%

34.90%

48.80%

9.30%

3.10%

A PEG may help my lungs.
(o=129)

1.60%

31.00%

41.10%

18 .60%

7.80%

A PEG may give me more energy.
(n=l29)

6.20%

45.00%

34.10%

12.40%

2.30%

If I was losing weight, I would want
a PEG. (o=l29)

6.20%

22.50%

28.70%

27.90%

14.70%

If ny appetite got worse, I would

3.80%

23 .80%

29.20%

32.30%

10.80%

I kl OW enough about the good and
ha• things about PEG tubes.
(n=l30)

3.80%

11.50%

35.40%

33 .10%

16.20%

If I needed extra nutrition, I would
pnfer a oasogastric (NG) tube.
(o=l29)

7.80%

11.60%

38.00%

20.20%

22.50%

Statement

M)

wo~ld

wamt a PEG. (o=l30)
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Table 7 Frequencies of Parents' Responses to Non-PEG Questionnaire
Stattement

Strongly
Agree

Agree

No
Opinion

Disagree

Strongly
Disagree

My child's weight i:s a problem. (n=l27)

8.70%

24.40%

6.30%

36.20%

24.40%

My child doesn't w~nt to gain weight.
(n=l27)

3.90%

5.50%

22.80%

39.40%

28.30%

My child doesn't eat enough.(n=l27)

3.90%

19.70%

6.30%

44.10%

26.00%

CF patients with lung problems need a
PEG.(n=l25)

0.00%

12.80%

44.80%

29.60%

12.80%

CF patients with n(J) lung problems do
not need a PEG.(n=l27)

2.40%

15.00%

57.50%

18.90%

6.30%

It would be bard to do sports or other
activities with a PEG.(n=l27)

4.70%

31.50%

30.70%

30.70%

2.40%

A PEG looks bad.(o=l27)

7.80%

38.30%

30.70%

21.30%

1.60%

A PEG would embarrass my
cbild.(n=l27)

18.90%

36.20%

24.40%

20.50%

0.00%

A PEG would be painful for my
child.(n=l 26)

7.10%

30.20%

39.70%

23.00%

0.00%

Getting a PEG means my child's CF is
getting worse. (n=l 27)

12.60%

37.00%

21.30%

26.80%

1.60%

My insurance/HMO/Medicaid would
pay for the formula used in PEG
feedings. (n=l2S)

2.40%

20.00%

61.60%

8.00%

8.00%

A PEG would help my child grow taller,
gain weight, and/or develop puberty.

5.50%

33.90%

44 .10%

12.60%

3.90%

A PEG may help my child's lungs.
(o=l27)

3.10%

21 .30%

44 .10%

25.00%

5.50%

A PEG may give my child more energy.
(n=l26)

4.00%

38.90%

38.90%

15 .10%

3.20%

If my child was losing weight, I would
want him or her to have a PEG. (n=127)

6.30%

41.70%

31.50%

17.30%

3.10%

If my child's appetite got worse, I would
want him or her to have a PEG. (n=l26)

4.00%

34.10%

34.10%

24.60%

3.20%

1 know enough about the good and bad
things about PEG tubes. (n=l27)

4.70%

15.70%

16.50%

37.80%

25.20%

If my child needed extra nutrition, I

3.90%

8.70%

41.70%

24.40%

21.30%

would prefer a nasogastric (NG) tube for
him or her. (n=l27)
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child was losing weight, the parents were more apt to consider PEG placement. However,
if nutrition support was indicated, parents were more likely to prefer an NG tube.

PEG vs. Non-PEG

An independent t-test revealed highly significant differences between the responses
of people with a PEG and people without a PEG reported in Table 8.
People with a PEG felt that it did not interfere with participation in sports and other
activities; look bad; cause embarrassment; or cause pain. However, those people without a
PEG thought that a PEG would make it hard to participate in sports and other activities; it
would look bad; would cause embarrassment; and would be painful. Those with a PEG did
not see placement of the PEG as a sign that their CF was getting worse and felt that the
PEG helped them grow. On the other hand, people without a PEG saw PEG placement as

Table 8 PEG vs. Non-PEG Mean Results
Variable

PEG Mean

Non-PEG Mean

2-tailed p values

Age (years)

12 60±:6.03
N=35
75 .42±:32 .07
N=35
17.38±:2.64
N=30
15.11:!::18.78
N=3 4
3 66±:1.06
N=35
1.44±:0.73
N=36
3.39±: 1.29
N=36
3.42±: 1.27
N=36
361±:1.18
N=36
3.81±:1.09
N=36
3.36±:1.22
N=36
l.92±:Q .94

16.0l:_t:13.00
N=202
89.79±:48.79
N=194
19.21±:3.98
N=159
7.28±:15.36
N=199
4.11 ±:0.96
N=200
3.30±:1.29
N=202
2 73±:0.96
N=201
2.53±:0.97
N=202
2.44±:1.06
N=202
2 76±:0.88
N=201
2.58±:1.05
N=202
2.74±:Q.87

0.014

Weight (pounds)
BMI
Days Hospitalized
Overall Health Last Year
Weight Problem
Sports
Looks
Embarrass
Painful
Worse
Grow

0.029
0.016
0.008
0.012
0.000
0.006
0.000
0.000
0.000
0.000
0.000
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a sign that the CF was getting worse and did not know if the PEG would help them grow.
Covariant analysis was conducted to determine potential confounding factors the
differences reported. Age was found to be a possible confounding factor to the responses
regarding looks, sports, and the perception of CF getting worse with PEG placement.
Gender may have also confounded differences seen in the responses to the statement
regarding participation in sports and other activities.
An attitude score based on participants responses to the questionnaire statements

revealed that people with a PEG had a more positive attitude toward placement than those
without a PEG. A score of 1 was the most positive, a score of 3 was neutral, and a score
of 5 was most negative toward PEG placement. The mean score for the PEG questionnaire
was 2.35±0.59, and the mean score for the non-PEG questionnaire was 3.12±0.544.

Professional Questionnaire

Questionnaires were returned from professionals working with patients with CF in
Idaho, Utah, Colorado, New Mexico, and Arizona. Table 9 describes the demographics of
the professionals and how they defined a weight and lung problem.
If a patient was not consuming enough calories orally, 56.5% of the professionals

would recommend gastrostomy feedings. Eighty-eight percent of the professionals
reported that a gastrostomy would not make it difficult for the patient to participate in
sports and other activities. A gastrostomy was not thought to look bad nor be painful for
the patient by 73.8% and 65.6% of the professionals. Seventy-one percent of the
professionals did not view the gastrostomy placement as an indication that the patient's CF
was getting worse. Payment for the formula used in gastrostomy feedings was thought to
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Table 9 Professional Characteristics and Definitions
Percentage

Variable
Profession (n=65)
Pulmonologist

21.5%

Gastroentrologist

6.2%

Nurse

32.3%

Social Worker

4.6%

Dietitian

16.9%

Respiratory Therapist

6.2%

Researcher

1.5%

Other

10.8%

Professional Definitions
Weight Problem (Expected weight for height) (n=63)

1.6%

:;:95%
:;:90%

25.4%

:;:85%

30.2%

:;:80%

22.2%

:;:75%

20.6%

Lung Problem (Percent expected FEV 1) (n=57)

10.5%

:;:90%
:;:80%

45.6%

:;:70%

26.3%

:;:60%

14%

:;:50%

3.5%

be a problem by 78.5% of the professionals. Gastrostomy feedings were reported to help
patients grow, improve their puhnonary status, and give them more energy by 80%, 73.8%,
and 93.8% of the professionals. Seventy-three percent of the professionals felt that
patients did not know enough about the pros and cons of a gastrostomy. Table 10 shows
the mean and median responses to the statements in the professional questionnaire. Table
11 shows the frequencies of responses to the professional questionnare.

Discussion

Demographics for the respondents to the non-PEG questionnaire were similar to
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Table 10 Professional Questionnaire Mean/Median Response
Statement
!fa patient isn ' t eating enough, I would recommend gastrostomy
feedings.
A gastrostomy makes it difficult for a patient to participate in sports
and other activities.
A gastrostomy looks bad.

A gastrostomy is embarrassing for the patient.

A gastrostomy is painful for the patient.

Gastrostomy placement means the patient's CF is gening worse.

Payment for the formula used in gastrostomy feedings is a problem.

Gastrostomy feedings help patients grow taller, gain weight, or
develop puberty.
Gastrostomy feedings improve pulmonary functions.

Gastrostomy feedings give the patient more energy.

Patients know enough about the pros and cons ofa gastrostomy.

Mean/Median Response
2 .50:!;1.05
2.00
N=62
4.05:!;0.84
4.00
N=65
3.75:!;1.00
4.00
N=65
2.95:!;1.03
3.00
N=64
3.58:!;0.97
4 .00
N=64
3.63:!;0.94
4.00
N=65
2.09:!;0.90
2.00
N=65
1.97:!;0.79
2.00
N=65
2.15:!;0.85
2.00
N=65
1.83:!;0.52
2.00
N=65
3.72:!;0.83
4.00

Response Key: I =strongly agree, 2=agree, 3=no opinion, 4=disagree, 5=strongly disagree

that of the National Cystic Fibrosis Patient Registry. Fifty-three percent of the patients
registered with the CF Foundation were male, and 51% ofthe non-PEG questionnaire
respondents were male showing a good representation of gender for the CF population (9).
The national mean age was 16.4 years, and the mean age for the non-PEG questionnaire
respondents was 16 years (9). The PEG questionnaire respondents differed significantly in
gender, as 72% were female. This may be due to the fact that more females have a PEG.
Females tend to have more severe nutritional complications particularly during
adolescence, and, hence, more of them have a PEG. The PEG questionnaire respondents
were significantly younger than the non-PEG questionnaire respondents. This once again

39
may be attributed to more PEGs placed in younger patients. The mean BMI was also
significantly lower in the PEG questionnaire respondents indicating these patients had a
greater challenge with weight.

Table 11 Frequencies of Responses to Professional Questionnaire
Statement

strongly

agree

DO

disagree

disagree

opinion

agree

strongly

Ifa patient isn ' t eating enough, I
would recommend gastrostomy
feedings (n=62)

17.70%

38.70%

19.40%

24.20%

0.00%

A gastrostomy makes it difficult for
a patient to participate in sports and
other activities. ( n=65)

1.50%

6.20%

4.60%

61.50%

26.20%

A gastrostomy looks bad. (n=65)

i .50%

15.40%

9.20%

53.80%

20.00%

A gastrostomy is embarrassing for
the patient. ( n=64)

0.00%

45.30%

23 .40%

21.90%

9.40%

A gastrostomy is painful for the
patient. (n=64)

1.60%

17.20%

15.60%

53.10%

12.50%

Gastrostomy placement means the
patient 's CF is getting worse.
(n=65)

0.00%

20.00%

9.20%

58.50%

12.30%

Payment for the formula used in
gastrostomy feedings is a problem.
(n=65)

23 .10%

55.40%

12.30%

7.70%

1.50%

Gastrostomy feedings help patients
grow taller, gain weight, or develop
puberty. (n=65)

27.70%

52 .30%

15 .40%

4.60%

0.00%

Gastrostomy feedings improve
pulmonary functions . (n=65)

20.00%

53.80%

16 .90%

9.20%

0.00%

Gastrostomy feedings give the
patient more energy. (n=65 )

23 .10%

70.80%

6.20%

0.00%

0.00%

Patients know enough about the
pros and cons of a gastrostomy.
(n=64)

0.00%

12.50%

14 .10%

62.50%

10.90%

In order for respondents to remain anonymous and confidentiality maintained, the
non-responders were not identified in this study. This may have introduced some bias to
the results; however, the demographics ofresponders and nonresponders were similar. The
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nonresponders may not be as compliant as the responders, and compliance largely
influences the outcome of a PEG. Further research of compliance and success of PEG
placement needs to be conducted.
The responses to the PEG questionnaire showed that patients with a PEG were
positive about PEG placement. Inadequate weight gain or maintenance and deficient oral
consumption of calories influenced the decision of whether or not to place a PEG. The
responses to the non-PEG questionnaire revealed that patients without a PEG were
apathetic towards PEG placement and more concerned that the PEG would interfere with
sports, be embarrassing, look bad, and be painful.
The lack of knowledge expressed on the responses to the non-PEG questionnaire
and professionals acknowledging a knowledge deficit in patients understanding of PEG
placement indicates a need for further patient education. Insights from expert nurses in
long-term gastrostomy placement talked about the importance of parent learning in making
the decision to place a PEG (10). Providing parents and patients with information about
the benefits and costs of a PEG prior to placement time provides tools to make the decision
regarding placement. The expert nurses emphasized the need for anticipatory planning in
making the decision to place a PEG and adjusting to life with a PEG. An important
strategy in this approach was to have experienced parents talk with parents who might be
considering PEG placement. Since the patients with a PEG have found that a PEG does
not look bad, is not embarrassing, does not interfere with sports, and is not painful, they
could help market the positive aspects of a PEG. A list of patients with a PEG who
consented to talk with patients considering a PEG placement could be developed, and the
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multi-disciplinary team would make appropriate referrals. Developing a video of patients
with a PEG participating in various activities and modeling the PEG could be another way
to share the gastrostomy experience. Education needs to be focused on the positive
benefits of PEG placement such as improved growth and increased energy.
Misconceptions about a PEG interfering with sports and other activities and a PEG being
painful need to be cleared up.
This study has shown that PEG placement can be a positive experience and that
those patients without a PEG lack in knowledge of the benefits of a PEG. Further
education of patients with CF about PEG placement would be very beneficial.
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CHAPTER IV
GENERAL CONCLUSION

PEG placement improves weight and height; however, if pulmonary function is
already compromised, PEG placement may contribute to worsening lung function. Earlier
placement rather than later improves nutrition status, yet there are barriers toward
placement.
People with CF with a PEG have a positive attitude and do not feel that it is
embarrassing, painful, or looks bad. Parents and /or patients with CF without a PEG lack
knowledge about PEG placement and have no opinion regarding various aspects of a PEG.
Patients with CF and their families need more education regarding the cost and
benefits of PEG placement. Discussion of PEG placement needs to be done as part of the
anticipatory guideline CFF recommendations to prevent unnecessary malnutrition.
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Dear Friends,
We need your help in completing the surveys enclosed in this letter. Sometimes people with CF
cannot eat enough food to meet their high energy needs. They may have problems gaining weight,
not being hungry, or not being able to eat enough. When this happens, the person needs to be fed
in another way. We are trying to find out what people with cystic fibrosis and/or their families
think about the use of feeding tubes.
These surveys are being mailed to patients seen at:
Intermountain Cystic Fibrosis Center-Primary Children's Medical Center (Salt Lake City, Utah)
University of Utah Medical Center (Salt Lake City, Utah)
CF Satellite Centers (Pocatello and Boise, Idaho)
The surveys should take no more than I 0 minutes each to complete. All information collected from
the surveys will remain strictly confidential. You do not need to put your name on the survey. No
individual will be identified. Your return of the completed survey serves as consent to participate
in the study. Please fill out the green survey and return in the enclosed envelope. If your child is
between the ages of I 0 to 18 years, please explain the study as needed and give him or her the Jetter
with the pink survey. You will find in this packet the following:
A letter for a person with CF between ages 10 to 18 years
A pink survey for:
A person with CF at least 10 years old
A green survey for:
The parent(s) or guardian(s) of a person with CF under the age of 18 years
A yellow sheet describing a certain type of feeding tube
Please read the yellow sheet before you complete the survey.
A self-addressed stamped envelope
If you have any questions concerning the study, please contact Katie McDonald, MS RD or Sarah
Gunnell, RD at (801) 588-3898. Thank you for your time and interest in improving the quality of
life of people with cystic fibrosis.
Sincerely,

Katie McDonald, M.S. R.D.
Clinical Dietitian
Primary Children's Medical Center
Sarah Gunnell, R. D.
Graduate Student
Utah State University
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Dear Friends,
We need your help in completing the surveys enclosed in this letter. We are trying to find out what
people with cystic fibrosis who have a gastrostomy and/or their families think about it.
These surveys are being mailed to patients seen at:
lntermountain Cystic Fibrosis Center-Primary Children's Medical Center (Salt Lake City, Utah)
University of Utah Medical Center (Salt Lake City, Utah)
CF Satellite Centers (Pocatello and Boise, Idaho)
The surveys should take no more than I 0 minutes each to complete. All information collected from
the surveys will remain strictly confidential. You do not need to put your name on the survey. No
individual will be identified. Your return of the completed survey serves as consent to participate
in the study. Please fill out the blue survey and return in the enclosed envelope. If your child is
between the ages I 0 to 18 years, please explain the study as needed and give him or her the letter
with the tan survey. You will find in this packet the following:
A letter for a person with CF between ages I 0 to 18 years
A tan survey for:
A person with CF at least l 0 years old who has a gastrostomy feeding tube
A blue survey for:
The parent(s) or guardian(s) of a person with CF under the age of 18 years who has a gastrostomy
feeding tube
A yellow sheet describing a certain type of feeding tube
Please read the yellow sheet before you complete the survey.
A self-addressed stamped envelope
If you have any questions concerning the study, please contact Katie McDonald, MS RD or Sarah
Gunnell, RD at (801) 588-3898. Thank you for your time and interest in improving the quality of
life of people with cystic fibrosis.
Sincerely,

Katie McDonald, M.S. R.D.
Clinical Dietitian
Primary Children's Medical Center

Sarah Gunnell, R. D.
Graduate Student
Utah State University
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Different Ways of Providing Nutrition

People with cystic fibrosis may not always be able to eat enough food for normal growth.
When this happens, they may choose to provide nutrition through a feeding tube. One
type of feeding tube is called a nasogastric (NG) feeding tube. This is placed through the
nose into the stomach. Another type of tube is a percutaneous endoscopic gastrostomy,
better known as PEG. It is placed directly into the stomach through the skin. The picture
below shows what a gastrostomy looks like. Once the feeding tube is placed, the person is
able to receive food through it. The food is in a liquid form and contains protein,
carbohydrates, fats, vitamins, and minerals.

gastrostomy
feeding

Figure 1 Gastrostomy Feeding
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Dear CF Friend,
Some children with cystic fibrosis (CF) gain weight slowly. Sometimes children with CF
are smaller than their friends. A feeding tube is one way of helping a person with CF to
gain weight and grow taller. You may have a feeding tube or you may know someone
who does.
We would like to know what you think about feeding tubes. We are sending this Jetter to
all of the children with CF older than 10 years who are seen in the CF outpatient clinic at
Primary Children's Medical Center. Your answers to these questions will help the CF
center understand what people with CF think about gaining weight and using feeding
tubes.
Your parents can help you ifthere are parts of the questions you don't understand. But,
we want to know what YOU think about the questions, not what your parents think.
They have their own set of questions to answer.
You don't have to answer these questions if you don't want to . You can throw these
papers away.
If you do answer these questions, do not write your name on the papers. We don't want
to know which child with CF is answering the questions. We will count the number of
different answers to each question and then tell what the numbers were. For example, we
will say, " For question XYZ, 50 people said, 'No ' and 20 people said, 'Yes."'
If you answer the questions and send the sheet back to us, your answers will be used in
our study. Give these papers back to your parents when you are done. They will send
your answer sheet and their answer sheet back to us.

Thanks for reading this letter. We hope you will answer the questions so that we can learn
more about what children with CF think about gaining weight and using feeding tubes.
Sincerely,

Katie McDonald, M.S. R.D.
Clinical Dietitian
Primary Children's Medic,:al Center
Sarah Gunnell, R. D.
Graduate Student
Utah State University
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Attitudes Toward Percutaneous Endoscopic Gastrostomy (PEG)
Questionnaire for People Who DO NOT Have PEG
Age_ _
Date
I

Weight_ _
I

Height_ _

Male

Female

Zip Code _ __

Number of days hospitalized in last year _ __
Physician or cystic fibrosis team has recommended the placement ofa PEG. Yes

No

What is your overall health in the last year? _very poor _poor _okay _good _very good
What is your level of physical activity in the last year compared to other people your age?
much less active
less active
about the same
more active
much more active

Please circle the number below each statement that best expresses your opinion of the statement.
1. My weight is a problem.
5 =strongly disagree
1 =strongly agree
2 =agree
3 = no opinion
4 = disagree
2. I don't want to gain weight.
1 =strongly agree
2 =agree

3 = no opinion

4 = disagree

5 =strongly disagree

3. My family or friends think I don't eat enough.
I =strongly agree
2 =agree
3 = no opinion

4 = disagree

5 =strongly disagree

4. CF patients with lung problems need a PEG .
J =strongly agree
2 =agree
3 = no opinion

4 = disagree

5 =strongly disagree

5. CF patients with no lung problems do not need a PEG.
2 =agree
3 = no opinion
I =strongly agree

4 = disagree

5 =strongly disagree

6. It would be hard to do sports or other activities with a PEG.
J =strongly agree
2 =agree
3 = no opinion

4 = disagree

5 =strongly disagree

7. A PEG looks bad.
I =strongly agree

2 =agree

3 = no opinion

4 = disagree

5 =strongly disagree

8. A PEG would embarrass me.
1 =strongly agree
2 =agree

3 = no opinion

4 = disagree

5 =strongly disagree

3 = no opinion

4 = disagree

5 =strongly disagree

10. Getting a PEG means my CF is getting worse.
1 =strongly agree
2 =agree
3 = no opinion

4 =disagree

5 =strongly disagree

9. A PEG would hurt.
1 =strongly agree

2 =agree

11. My insurance/HMO/Medicaid would pay for the formula used in PEG feedings .
1 =strongly agree
2 =agree
3 = no opinion
4 = disagree

5 =strongly disagree

12. A PEG would help me grow taller, gain weight, or develop puberty.
I =strongly agree
2 =agree
3 = no opinion
4 =disagree

5 =strongly disagree

13. A PEG may help my lungs.
I =strongly agree
2 =agree

3 =no opinion

4 = disagree

5 =strongly disagree

14. A PEG may give me more energy.
J =strongly agree
2 =agree

3 = no opinion

4 =disagree

5 =strongly disagree

15. !fl was losing weight, I would want a PEG.
J =strongly agree
2 =agree
3 = no opinion

4 = disagree

5 =strongly disagree

16. If my appetite got worse, I would want a PEG .
1 =strongly agree
2 =agree
3 =no opinion

4 =disagree

5 =strongly disagree

17. I know enough about the good and bad things about PEG tubes.
I =strongly agree
2 =agree
3 = no opinion
4 = disagree

5 =strongly disagree

18. !fl needed extra nutrition, I would prefer a nasogastric (NG) tube.
J =strongly agree
2 =agree
3 = no opinion
4 = disagree

5 =strongly disagree
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Attitudes Toward Percutaneous Endoscopic Gastrostomy (PEG)
Questionnaire for Parents of People Who DO NOT Have PEG
Patient Information
Age__ Weight_ _
I Date- -I- - -

Height__

Male

Female

Zip Code _ __

Number of days hospitalized in last year _ __
Physician or cystic fibrosis team has recommended the placement ofa PEG. Yes
No
What is your child's overall health in the last year? _very poor _poor _okay _good _very good
What is your child's level of physical activity in the last year compared to other people your age?
much less active
less active
about the same
more active
much more active

Please circle the number below each statement that best expresses your opinion of the statement.
I. My child's weight is a problem .
I =strongly agree
2 =agree

3 = no opinion

4 =disagree

5 =strongly disagree

2. My child doesn't want to gain weight.
I =strongly agree
2 =agree

3 = no opinion

4 =disagree

5 =strongly disagree

3. My child doesn't eat enough.
I =strongly agree
2 =agree

3 = no opinion

4 = disagree

5 =strongly disagree

4. CF patients with lung problems need a PEG .
I =strongly agree
2 =agree
3 = no opinion

4 = disagree

5 =strongly disagree

5. CF patients with no Jung problems do not need a PEG.
2 =agree
3 = no opinion
I =strongly agree

4 = disagree

5 =strongly disagree

6. It would be hard to do sports or other activities with a PEG .
l =strongly agree
2 =agree
3 = no opinion

4 = disagree

5 =strongly disagree

7. A PEG looks bad.
1 =strongly agree
8.

2 =agree

3 = no opinion

4 = disagree

5 =strongly disagree

A PEG would embarrass my child.
l =strongly agree
2 =agree

3 = no opinion

4 =disagree

5 =strongly disagree

9. A PEG would be painful for my child.

I =strongly agree

2 =agree

3 = no opinion

4 = disagree

5 =strongly disagree

10. Getting a PEG means my child's CF is getting worse.
I =strongly agree
2 =agree
3 = no opinion

4 = disagree

5 =strongly disagree

11. My insurance/HMO/Medicaid would pay for the formula used in PEG feedings .
I =strongly agree
2 =agree
3 = no opinion
4 = disagree

5 =strongly disagree

12. A PEG would help my child grow taller, gain weight, and/or develop puberty.
I =strongly agree
2 =agree
3 = no opinion
4 =disagree

5 =strongly disagree

13. A PEG may help my child's lungs.
I =strongly agree
2 =agree

3 =no opinion

4 =disagree

5 =strongly disagree

14. A PEG may give my child more energy.
I =strongly agree
2 =agree

3 = no opinion

4 =disagree

5 =strongly disagree

15. If my child was losing weight, I would want him or her to have a PEG.
1 =strongly agree
2 =agree
3 = no opinion
4 =disagree

5 =strongly disagree

16. If my child's appetite got worse, I would want him or her to have a PEG .
1 =strongly agree
2 =agree
3 =no opinion
4 =disagree

5 =strongly disagree

17. I know enough about the good and bad things about PEG tubes.
I =strongly agree
2 =agree
3 = no opinion
4 =disagree

5 =strongly disagree

18. lfmy child needed extra nutrition, I would JJrefer a nasogastric (NG) tube for him or her.
4 =disagree
5 =strongly disagree
1 =strongly agree
2 =agree
3 =no opinion
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Attitudes Toward Percutaneous Endoscopic Gastrostomy (PEG)
Questionnaire for People Who Have PEG
Age__

Weight_ _

Height_ _

Male

Female

Zip Code _ _ _ Date _ _ _ _!__

Number days hospitalized in last year_ _
When was your PEG placed? _ _ month _ _ year
What is your overall health in the last year? _very poor _poor _

okay _good _very good

What is your level of activity in the last year compared to other people your age?
much less active
less active
about the same
more active

much more active

Please circle the number below each statement that best expresses your opinion of the statement.
1. When my PEG tube was placed, I had healthy lungs.
I =strongly agree
2 =agree
3 = no opinion

4 = disagree

5 =strongly disagree

2. My weight was a problem when the PEG was placed.
1 =strongly agree
2 =agree
3 =no opinion

4 = di sagree

5 =strongly disagree

3. I ate enough before my PEG was placed.
1 =strongly agree
2 =agree

3 = no opinion

4 =disagree

5 =strongly disagree

4. I have gained weight with my PEG .
1 =strongly agree
2 =agree

3 = no opinion

4 = di sagree

5 =strongly disagree

5. I thought that gett ing a PEG meant my CF was getting worse.
I =strongly agree
2 =agree
3 = no opinion

4 = disagree

5 =strongly disagree

6. My PEG makes it hard to do sports or other activities.
I =strongly agree
2 =agree
3 = no opinion

4 =disagree

5 =strongly disagree

7. I think my PEG looks bad.
1 =strongly agree
2 =agree

3 = no opinion

4 = disagree

5 =strongly disagree

8. I would be embarrassed if my friends knew I had a PEG .
1 =strongly agree
2 =agree
3 = no opinion

4 = disagree

5 =strongly disagree

9. My PEG hurts .
1 =strongly agree

3 = no opinion

4 = disagree

5 =strongly disagree

10. My family has trouble buying the formula .
1 =strongly agree
2 =agree
3 = no opinion

4 = disagree

5 =strongly disagree

11 . The PEG has helped me grow taller, gain weight, and/or develop puberty.
1 =strongly agree
2 =agree
3 = no opinion
4 = disagree

5 =strongly disagree

12. The PEG has helped my lungs.
2 =agree
1 =strongly agree

3 = no opinion

4 =disagree

5 =strongly disagree

13 . I have more energy with my PEG .
2 =agree
1 =strongly agree

3 = no opinion

4 =disagree

5 =strongly disagree

14. I am healthier now after the PEG.
2 =agree
I =strongly agree

3 = no opinion

4 =disagree

5 =strongly disagree

4 = disagree

5 =strongly disagree

2 =agree

15 . IfI could do it over again , I would NOT have a PEG .
I =strongly agree

2 =agree

3 = no opinion
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Attitudes Toward Percutaneous Endoscopic Gastrostomy (PEG)
Questionnaire for Parents of People Who Have PEG
Patient Information
Zip Code _ _ _ Date __! __! __
Age__
Weight_ _ Height_ _ Male
Female
Number of days hospitalized in last year_ _
When was your child's PEG placed? _ _ month _ _ year
What is your child's overall health in the last year? _very poor _poor _okay _good _very good
What is your child's level of activity in the last year compared to other people his or her age?
much less active
less active
about the same
more active
much more active

Please circle the number below each statement that best expresses your opinion of the statement.
1. When my child's PEG tube was placed, he or she had healthy lungs.
1 =strongly agree
2 =agree
3 = no opinion
4 = disagree

5 =strongly disagree

2. My child's weight was a problem when the PEG was placed.
1 =strongly agree
2 =agree
3 = no opinion

4 =disagree

5 =strongly disagree

3. My child ate enough before his or her PEG was placed .
1 =strongly agree
2 =agree
3 = no opinion

4 = disagree

5 =strongly disagree

4. My child has gained weight with his or her PEG.
1 =strongly agree
2 =agree
3 = no opinion

4 = disagree

5 =strongly disagree

5. I thought that getting a PEG meant my child's CF was getting worse .
1 =strongly agree
2 =agree
3 = no opinion
4 = disagree

5 =strongly disagree

6. My child's PEG makes it hard for him or her to do sports or other activities.
1 =strongly agree
2 =agree
3 = no opinion
4 = disagree

5 =strongly disagree

7. My child's PEG looks bad .
1 =strongly agree
2 =agree

5 =strongly disagree

3 = no opinion

4 =disagree

8. My child would be embarrassed if his or her friends knew he or she had a PEG .
I =strongly agree
2 =agree
3 = no opinion
4 = disagree

5 =strongly disagree

9. My child's PEG is painful.
I =strongly agree
2 =agree

3 = no opinion

4 =disagree

5 =strongly disagree

10. We have difficulty affording the formula.
1 =strongly agree
2 =agree
3 = no opinion

4 =disagree

5 =strongly disagree

11. The PEG has helped my child grow taller, gain weight, and/or develop puberty.
1 =strongly agree
2 =agree
3 = no opinion
4 = disagree

5 =strongly disagree

12. The PEG has helped my child's lungs.
1 =strongly agree
2 =agree

3 = no opinion

4 =disagree

5 =strongly disagree

13. My child has more energy with his or her PEG.
1 =strongly agree
2 =agree
3 = no opinion

4 =disagree

5 =strongly disagree

14. My child is healthier now after the PEG.
1 =strongly agree
2 =agree

4 =disagree

5 =strongly disagree

4 = disagree

5 =strongly disagree

3 = no opinion

15 . !fl could do it over again, my child would NOT have a PEG.
1 =strongly agree
2 =agree
3 =no opinion
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July 21, 2000

Dear Cystic Fibrosis Team Member:
You are invited to complete a questionnaire regarding the attitudes of professionals
toward gastrostomies. This past spring questionnaires were sent to measure the
attitudes of people with CF and/or their families toward gastrostomy placement in
the mountain west region. The Mountain West Consortium identified the need to
assess the attitudes of professionals toward gastrostomy placement. As a followup, you are invited to complete the enclosed questionnaire for professionals
regarding gastrostomy placement. All responses will remain strictly confidential.
Names will not be used for this study, but we are requesting you to list your
professional discipline. Only Nedra K. Christensen, Priniciple Investigator for this
study, Sarah Gunnell, a Utah State University graduate student, and Katie
McDonald, from lntermountain Cystic Fibrosis Clinic will have access to this data.
The questionnaires will be kept in a locked file cabinet in Dr. Christensen's office.
Please return the completed questionnaire in the enclosed envelope. If you have
any questions, please contact Katie McDonald or Sarah Gunnell at (801) 588-3898
or Nedra K. Christensen (801) 484-9374. Thank you for your participation and
willingness to help improve nutritional therapy in people with CF.
Sincerely,

Nedra K. Christensen PhD, RD
RD
Assistant Professor
Utah State University
Medical
Logan, UT 84322-8700

Sarah Gunnell, RD

Katie McDonald MS,

Graduate Student
Utah State University

Clinical Dietitian
Primary Children's

Logan, UT 84322-8700

Center
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Appendix J
Attitudes Toward Gastrostomy Placement in People with Cystic Fibrosis
Questionnaire for Professionals
Date
I

I

Please mark your profession.
Pu/monologist__ Gastroentrologist __
Respiratory Therapist__
Researcher

Nurse

Social Worker
Dietitian
Other _ _ please specify_ _ _ _ _ __

How many patients have you recommended gastrostomy placement to within the past year? _ _
Please describe the current criteria for placing a gastrostomy as you understand it.

. Please circle the number below each statement that best expresses your opinion of the statement.
I. I would define a weight problem as: (in terms of expected weight for height).
I .:::. 95%
2 .:::. 90%
3 .:::. 85%
4.:::. 80%
5 .:::. 75%
2. What percentage of patients don't want to gain weight?
I =5-10%
2 = 11-20%
3 = 30-50%

4

=

60-75%

5 = 90-100%

3. Lung problems would be described as FEY 1 of: (expressed in percent expected).
1 .:::.90%
2 .:::.80%
3 go%
4 .:::.60%
s .:::.so%
4. If a patient isn't eating enough, I would recommend gastrostomy feedings.
1 =strongly agree
2 =agree
3 = no opinion
4 = disagree

5 =strongly disagree

5. A gastrostomy makes it difficult for a patient to participate in sports and other activities.
4 = disagree
5 =strongly disagree
I =strongly agree
2 =agree
3 = no opinion
6. A gastrostomy looks bad .
I =strongly agree

2 =agree

3 = no opinion

4 = disagree

5 =strongly disagree

7. A gastrostomy is embarrassing for the patient.
I =strongly agree
2 =agree
3 = no opinion

4 =disagree

5 =strongly disagree

8. A gastrostomy is painful for the patient.
I =strongly agree
2 =agree

4 =disagree

5 =strongly disagree

9. Gastrostomy placement means the patient's CF is getting worse.
4 = disagree
I =strongly agree
2 =agree
3 = no opinion

5 =strongly disagree

I 0. Payment for the formula used in gastrostomy feedings is a problem.
4 = disagree
1 =strongly agree
2 =agree
3 = no opinion

5 =strongly disagree

11. Gastrostomy feedings help patients grow taller, gain weight, or develop puberty.
I =strongly agree
2 =agree
3 = no opinion
4 = disagree

5 =strongly disagree

12. Gastrostomy feedings improve pulmonary functions.
I =strongly agree
2 =agree
3 = no opinion

4 =disagree

5 =strongly disagree

13. Gastrostomy feedings give the patient more energy.
1 =strongly agree
2 =agree
3 = no opinion

4 =disagree

5 =strongly disagree

14. Patients know enough about the pros and cons of a gastrostomy.
4 =disagree
I =strongly agree
2 =agree
3 = no opinion

5 =strongly disagree

3 = no opinion

